Publicacións (21) Publicacións de RÓSULA MERCEDES GARCÍA NAVAS

2024

  1. Combined HRAS and NRAS ablation induces a RASopathy phenotype in mice

    Cell Communication and Signaling, Vol. 22, Núm. 1

2023

  1. Characterization of mutant versions of the R-RAS2/TC21 GTPase found in tumors

    Oncogene, Vol. 42, Núm. 5, pp. 389-405

  2. Critical requirement of SOS1 for tumor development and microenvironment modulation in KRASG12D-driven lung adenocarcinoma

    Nature Communications, Vol. 14, Núm. 1

2022

  1. Critical Requirement of SOS1 for Development of BCR/ABL-Driven Chronic Myelogenous Leukemia

    Cancers, Vol. 14, Núm. 16

2021

  1. Anthraquinones as inhibitors of SOS RAS-GEF activity

    Biomolecules, Vol. 11, Núm. 8

  2. Critical requirement of SOS1 RAS-GEF function for mitochondrial dynamics, metabolism, and redox homeostasis

    Oncogene, Vol. 40, Núm. 27, pp. 4538-4551

  3. Functional specificity of the members of the sos family of ras‐gef activators: Novel role of sos2 in control of epidermal stem cell homeostasis

    Cancers, Vol. 13, Núm. 9

  4. Neutrophils drive endoplasmic reticulum stress-mediated apoptosis in cancer cells through arginase-1 release

    Scientific Reports, Vol. 11, Núm. 1

  5. Sos2 comes to the fore: Differential functionalities in physiology and pathology

    International Journal of Molecular Sciences, Vol. 22, Núm. 12

2018

  1. Differential role of the RasGEFs Sos1 and Sos2 in mouse skin homeostasis and carcinogenesis

    Molecular and Cellular Biology, Vol. 38, Núm. 16

2017

  1. Ras-GRF2 regulates nestin-positive stem cell density and onset of differentiation during adult neurogenesis in the mouse dentate gyrus

    Molecular and Cellular Neuroscience, Vol. 85, pp. 127-147

2016

  1. Sos1 disruption impairs cellular proliferation and viability through an increase in mitochondrial oxidative stress in primary MEFs

    Oncogene, Vol. 35, Núm. 50, pp. 6389-6402

2015

  1. Arginase activity and CD3ζ expression after major surgery

    Intensive Care Medicine

2014

  1. Arginase as a new concern in blood transfusion

    Blood Transfusion

2013

  1. Antitumor activity of new enantiopure pybox-ruthenium complexes

    Dalton Transactions, Vol. 42, Núm. 38, pp. 13955-13967

  2. Endowing indole-based tubulin inhibitors with an anchor for derivatization: Highly potent 3-substituted indolephenstatins and indoleisocombretastatins

    Journal of Medicinal Chemistry, Vol. 56, Núm. 7, pp. 2813-2827

2012

  1. Depletion of L-arginine induces autophagy as a cytoprotective response to endoplasmic reticulum stress in human T lymphocytes

    Autophagy, Vol. 8, Núm. 11, pp. 1557-1576

  2. Relación entre la actividad arginasa y el tiempo de conservación de los concentrados de hematíes

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 59, Núm. 6, pp. 315-320

2011

  1. The metalloprotease ADAM8 is associated with and regulates the function of the adhesion receptor PSGL-1 through ERM proteins

    European Journal of Immunology, Vol. 41, Núm. 12, pp. 3436-3442

2010

  1. Antitumor activity of new hydridotris(pyrazolyl)borate ruthenium(II) complexes containing the phosphanes PTA and 1-CH3-PTA

    Dalton Transactions, Vol. 39, Núm. 42, pp. 10186-10196